Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (241) 241
humans (208) 208
male (160) 160
female (152) 152
gastroenterology & hepatology (147) 147
middle aged (134) 134
adult (121) 121
aged (79) 79
liver (64) 64
transplantation (63) 63
treatment outcome (58) 58
liver transplantation (54) 54
liver diseases (50) 50
surgery (50) 50
cirrhosis (45) 45
analysis (40) 40
gastroenterology and hepatology (35) 35
liver cirrhosis (34) 34
risk factors (34) 34
prognosis (33) 33
abridged index medicus (30) 30
animals (28) 28
diagnosis (28) 28
adolescent (26) 26
mortality (26) 26
patients (26) 26
management (25) 25
prospective studies (25) 25
survival (25) 25
follow-up studies (24) 24
hepatitis c (24) 24
retrospective studies (24) 24
care and treatment (23) 23
time factors (22) 22
aged, 80 and over (21) 21
hypertension (21) 21
infection (21) 21
therapy (21) 21
young adult (21) 21
rats (20) 20
antiviral agents - therapeutic use (19) 19
hepatitis c, chronic - drug therapy (19) 19
genotype (18) 18
health aspects (18) 18
hepacivirus - genetics (18) 18
medical research (18) 18
portal hypertension (18) 18
biopsy (17) 17
drug therapy, combination (17) 17
hepatitis (17) 17
medicine, experimental (17) 17
belgium (16) 16
hepatitis c virus (16) 16
immunology (16) 16
portal-hypertension (16) 16
disease (15) 15
hepatocellular-carcinoma (15) 15
inflammation (15) 15
clinical trials (14) 14
gene expression (14) 14
interferon (14) 14
liver cirrhosis - complications (14) 14
predictive value of tests (14) 14
rodents (14) 14
fibrosis (13) 13
hepatocellular carcinoma (13) 13
hepatology (13) 13
immunohistochemistry (13) 13
prevalence (13) 13
radiology, nuclear medicine & medical imaging (13) 13
recipients (13) 13
sensitivity and specificity (13) 13
transplants & implants (13) 13
dose-response relationship, drug (12) 12
europe (12) 12
immunosuppressive agents - therapeutic use (12) 12
liver - pathology (12) 12
liver failure (12) 12
liver transplantation - adverse effects (12) 12
multivariate analysis (12) 12
recurrence (12) 12
research (12) 12
risk (12) 12
risk-factors (12) 12
transplantation of organs, tissues, etc (12) 12
treatment (12) 12
child (11) 11
drug therapy (11) 11
hepatitis c, chronic - virology (11) 11
kaplan-meier estimate (11) 11
kidney-disease (11) 11
liver cirrhosis - surgery (11) 11
reproducibility of results (11) 11
ribavirin (11) 11
studies (11) 11
tumors (11) 11
virology (11) 11
cholangitis (10) 10
cytokines (10) 10
double-blind (10) 10
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Diffusion-weighted MRI provides additional value to conventional dynamic contrast-enhanced MRI for detection of hepatocellular carcinoma
by Vandecaveye, Vincent and De Keyzer, Frederik and Verslype, Chris and Op de Beeck, Katya and Komuta, Mina and Topal, Baki and Roebben, Ilse and Bielen, Didier and Roskams, Tania and Nevens, Frederik and Dymarkowski, Steven
European Radiology, ISSN 0938-7994, 2009, Volume 19, Issue 10, pp. 2456 - 2466
The purpose of this study was to evaluate the accuracy of diffusion-weighted magnetic resonance imaging (DW-MRI) in differentiating HCC from benign cirrhotic... 
Cirrhosis | Lesion differentiation | Hepatocellular carcinoma | Diffusion-weighted MRI | HIGH-B-VALUE | IMAGING FINDINGS | HEPATIC-LESIONS | CHALLENGES | DYSPLASTIC NODULES | TRANSPLANTATION | THERAPY | CIRRHOTIC LIVER | LIVER LESION DETECTION | PATHOLOGICAL CORRELATION | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Diagnosis, Differential | Liver Cirrhosis - diagnosis | Reproducibility of Results | Carcinoma, Hepatocellular - diagnosis | Humans | Image Interpretation, Computer-Assisted - methods | Meglumine - analogs & derivatives | Organometallic Compounds | Algorithms | Contrast Media | Liver Neoplasms - diagnosis | Sensitivity and Specificity | Image Enhancement - methods | Diffusion Magnetic Resonance Imaging - methods | Liver cancer | Hepatoma | Magnetic resonance imaging | Liver cirrhosis | Histochemistry | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Reply to: ā€œDevelopment and validation of a polycystic liver disease complaint-specific assessment (POLCA) ā€“ Use of the Delphi technique for content validationā€
by Temmerman, Frederik and Nevens, Frederik
Journal of Hepatology, ISSN 0168-8278, 2014, Volume 62, Issue 4, pp. 989 - 989
Gastroenterology and Hepatology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Reply to: "Development and validation of a polycystic liver disease complaint-specific assessment (POLCA) - use of the Delphi technique for content validation"
by Temmerman, Frederik and Nevens, Frederik
Journal of hepatology, ISSN 0168-8278, 04/2015, Volume 62, Issue 4, pp. 989 - 989
Female | Liver Diseases - diagnosis | Male | Cysts - diagnosis | Humans | Self Report | Usage | Methods | Liver diseases | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Lanreotide reduces liver growth in patients with polycystic liver disease: further robust evidences but not the end of the story
by Frederik, Temmerman and Frederik, Nevens
Gastroenterology, 06/2019
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Further Evidence That Lanreotide Reduces Liver Growth in Patients With Polycystic Liver Disease, But Not the End of the Story
by Temmerman, Frederik and Nevens, Frederik
Gastroenterology, ISSN 0016-5085, 08/2019, Volume 157, Issue 2, pp. 298 - 299
WOMEN | SOMATOSTATIN ANALOGS | VOLUME | VALIDATION | POOLED ANALYSIS | KIDNEY | GASTROENTEROLOGY & HEPATOLOGY
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Everolimus halts hepatic cystogenesis in a rodent model of polycystic-liver-disease
by Frederik Temmerman Feng Chen Louis Libbrecht Ingrid Vander Elst Petra Windmolders Yuanbo Feng Yicheng Ni Humbert De Smedt Frederik Nevens Jos van Pelt
äø–ē•Œčƒƒč‚ ē—…å­¦ę‚åæ—ļ¼šč‹±ę–‡ē‰ˆ, ISSN 1007-9327, 2017, Volume 23, Issue 30, pp. 5499 - 5507
AIM To develop a MRI-based method for accurate determination of liver volume(LV) and to explore the effect of long-term everolimus(EVR) treatment on LV in PCK... 
mTOR inhibitor | Somatostatin analogue | Magnetic resonance imaging | Fibrocystic liver disease | Liver volume measurement | KIDNEY-DISEASE | VOLUME | liver volume measurement | somatostatin analogue | INDIVIDUAL PATIENT DATA | MTOR | INHIBITION | SOMATOSTATIN | PCK RAT MODEL | POOLED ANALYSIS | GASTROENTEROLOGY & HEPATOLOGY | PROGRESSION | SIROLIMUS | Cysts - drug therapy | Liver - pathology | Phosphorylation | TOR Serine-Threonine Kinases - metabolism | Humans | Liver Diseases - pathology | Liver Diseases - diagnostic imaging | Gene Expression Profiling | Phosphatidylinositol 3-Kinases - metabolism | Hypertension, Portal - prevention & control | TOR Serine-Threonine Kinases - antagonists & inhibitors | Liver Cirrhosis - diagnostic imaging | Liver - drug effects | Liver - diagnostic imaging | Everolimus - therapeutic use | Female | Drug Evaluation, Preclinical | Proto-Oncogene Proteins c-akt - metabolism | Real-Time Polymerase Chain Reaction | Disease Models, Animal | Liver Cirrhosis - drug therapy | Somatostatin - analogs & derivatives | Rats | Random Allocation | Cysts - pathology | Magnetic Resonance Imaging | Animals | Signal Transduction - drug effects | Cysts - diagnostic imaging | Ribosomal Protein S6 - metabolism | Liver Cirrhosis - pathology | Peptides, Cyclic - therapeutic use | Liver Diseases - drug therapy | Somatostatin - therapeutic use | Index Medicus | Basic Study
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Steroidal or non-steroidal FXR agonists ā€“ Is that the question?
by Verbeke, Len and Nevens, Frederik and Laleman, Wim
Journal of Hepatology, ISSN 0168-8278, 2017, Volume 66, Issue 4, pp. 680 - 681
Verbeke et al discuss the Farnesoid X receptor (FXR) has been identified as a master regulator of bile acid homeostasis, with endogenous bile acids serving as... 
Gastroenterology and Hepatology | Animal models | Liver diseases | Bile acids | Antiinflammatory agents | Liver | Homeostasis | Reabsorption | Inflammation | Chemical modification | Acids | Intestine | Fibrosis | Chenodeoxycholic acid | Cholestasis | Bile | Steroids | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Early Use of TIPS in Patients with Cirrhosis and Variceal Bleeding
by Garcƭa-PagƔn, Juan Carlos and Caca, Karel and Bureau, Christophe and Laleman, Wim and Appenrodt, Beate and Luca, Angelo and Abraldes, Juan G and Nevens, Frederik and Vinel, Jean Pierre and Mƶssner, Joachim and Bosch, Jaime and Early TIPS Cooperative Study Grp and Early TIPS (Transjugular Intrahepatic Portosystemic Shunt) Cooperative Study Group
The New England Journal of Medicine, ISSN 0028-4793, 06/2010, Volume 362, Issue 25, pp. 2370 - 2379
In this randomized trial involving patients with cirrhosis and acute variceal bleeding who were at high risk for treatment failure, control of bleeding was... 
MEDICINE, GENERAL & INTERNAL | METAANALYSIS | HEMORRHAGE | INTRAHEPATIC PORTOSYSTEMIC SHUNT | CLINICAL-TRIALS | PREVENTION | RANDOMIZED CONTROLLED-TRIAL | BACTERIAL-INFECTION | POLYTETRAFLUOROETHYLENE | PORTAL-HYPERTENSION | CONSENSUS WORKSHOP | Polytetrafluoroethylene | Hypertension, Portal - complications | Esophageal and Gastric Varices - therapy | Humans | Middle Aged | Liver Cirrhosis - mortality | Gastrointestinal Hemorrhage - surgery | Male | Gastrointestinal Hemorrhage - mortality | Gastrointestinal Hemorrhage - therapy | Adult | Female | Portasystemic Shunt, Transjugular Intrahepatic | Esophageal and Gastric Varices - mortality | Adrenergic beta-Antagonists - therapeutic use | Vasoconstrictor Agents - therapeutic use | Acute Disease | Liver Cirrhosis - complications | Esophageal and Gastric Varices - complications | Survival Rate | Treatment Outcome | Liver Cirrhosis - therapy | Hepatic Encephalopathy - complications | Gastrointestinal Hemorrhage - complications | Esophageal and Gastric Varices - surgery | Liver Cirrhosis - surgery | Care and treatment | United States | Mortality | Health aspects | Liver cirrhosis | Risk factors | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text In Memoriam: Jan De Groote (1925ā€“2018)
by Fevery, Johan and Desmet, Valeer and Nevens, Frederik
Journal of Hepatology, ISSN 0168-8278, 12/2018, Volume 69, Issue 6, pp. 1215 - 1216
An obituary for Prof Jan De Groote, who passed away at aged 93, is presented. De Groote will be remembered as the first Secretary General of EASL (1966-1969)... 
GASTROENTEROLOGY & HEPATOLOGY | College professors | Deaths | Liver
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Telaprevir for Retreatment of HCV Infection
by Zeuzem, Stefan and Andreone, Pietro and Pol, Stanislas and Lawitz, Eric and Diago, Moises and Roberts, Stuart and Focaccia, Roberto and Younossi, Zobair and Foster, Graham R and Horban, Andrzej and Ferenci, Peter and Nevens, Frederik and MĆ¼llhaupt, Beat and Pockros, Paul and Terg, Ruben and Shouval, Daniel and van Hoek, Bart and Weiland, Ola and Van Heeswijk, Rolf and De Meyer, Sandra and Luo, Don and Boogaerts, Griet and Polo, Ramon and Picchio, Gaston and Beumont, Maria and REALIZE Study Team
The New England Journal of Medicine, ISSN 0028-4793, 06/2011, Volume 364, Issue 25, pp. 2417 - 2428
In patients with HCV infection who did not have a sustained response to peginterferon plus ribavirin, the addition of telaprevir to this combination therapy... 
MEDICINE, GENERAL & INTERNAL | GENOTYPE 1 INFECTION | BOCEPREVIR | RIBAVIRIN | PEGINTERFERON ALPHA-2A | HEPATITIS-C | Recurrence | Humans | Middle Aged | Hepacivirus - genetics | Hepatitis C, Chronic - virology | Polyethylene Glycols - adverse effects | Male | RNA, Viral - blood | Recombinant Proteins | Oligopeptides - adverse effects | Polyethylene Glycols - therapeutic use | Viral Load | Oligopeptides - therapeutic use | Serine Proteinase Inhibitors - therapeutic use | Young Adult | Serine Proteinase Inhibitors - adverse effects | Adult | Female | Drug Therapy, Combination | Hepacivirus - isolation & purification | Double-Blind Method | Antiviral Agents - therapeutic use | Ribavirin - therapeutic use | Interferon-alpha - therapeutic use | Genotype | Logistic Models | Hepatitis C, Chronic - drug therapy | Sequence Analysis, DNA | Retreatment | Ribavirin - adverse effects | Antiviral Agents - adverse effects | Aged | Interferon-alpha - adverse effects | Peginterferon alfa-2a | Patient outcomes | Genetic aspects | Hepatitis C | Drug therapy | Comparative analysis | Health aspects | Liver diseases | Cytokines | Leukopenia | Anemia | Infections | Ribonucleic acid--RNA | Ribavirin | Manuscripts | Genotype & phenotype | Consent | Interferon | Drug dosages | Genotypes | Neutropenia | Pharmaceuticals | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
by Nevens, Frederik and Andreone, Pietro and Mazzella, Giuseppe and Strasser, Simone I and Bowlus, Christopher and Invernizzi, Pietro and Drenth, Joost P.H and Pockros, Paul J and Regula, Jaroslaw and Beuers, Ulrich and Trauner, Michael and Jones, David E and Floreani, Annarosa and Hohenester, Simon and Luketic, Velimir and Shiffman, Mitchell and van Erpecum, Karel J and Vargas, Victor and Vincent, Catherine and Hirschfield, Gideon M and Shah, Hemant and Hansen, Bettina and Lindor, Keith D and Marschall, Hanns-Ulrich and Kowdley, Kris V and Hooshmand-Rad, Roya and Marmon, Tonya and Sheeron, Shawn and Pencek, Richard and MacConell, Leigh and Pruzanski, Mark and Shapiro, David and POISE Study Grp and POISE Study Group and Sahlgrenska akademin and Institute of Medicine, Department of Molecular and Clinical Medicine and Institutionen fƶr medicin, avdelningen fƶr molekylƤr och klinisk medicin and Gƶteborgs universitet and Gothenburg University and Sahlgrenska Academy
The New England Journal of Medicine, ISSN 0028-4793, 08/2016, Volume 375, Issue 7, pp. 631 - 643
In this 12-month, placebo-controlled trial involving patients with primary biliary cholangitis who had an inadequate response to ursodiol, treatment with... 
CHANGING NOMENCLATURE | PBC | FXR | MEDICINE, GENERAL & INTERNAL | URSODEOXYCHOLIC ACID | PROGNOSIS | CIRRHOSIS | CHOLESTATIC PRURITUS | NONALCOHOLIC STEATOHEPATITIS | BIOCHEMICAL RESPONSE | SCALE | Liver Cirrhosis - etiology | Bile Acids and Salts - blood | Double-Blind Method | Humans | Middle Aged | Liver Cirrhosis, Biliary - drug therapy | Male | Chenodeoxycholic Acid - analogs & derivatives | Bone Density - drug effects | Chenodeoxycholic Acid - adverse effects | Fibroblast Growth Factors - blood | Chenodeoxycholic Acid - therapeutic use | Adult | Female | Aged | Liver Cirrhosis, Biliary - complications | Liver Cirrhosis, Biliary - blood | Alkaline Phosphatase - blood | Pruritus - chemically induced | Clinical trials | Ursodiol | Care and treatment | Usage | Dosage and administration | Cholangitis | Primary biliary cirrhosis | Alkaline phosphatase | Liver diseases | Syngeneic grafts | Liver | Bilirubin | Pruritus | Phosphatase | Patients | Cirrhosis | Allografts | Acids | Fibrosis | Drug therapy | Bile | Liver transplantation | Index Medicus | Abridged Index Medicus | Alkaline Phosphatase | Chenodeoxycholic Acid | Fibroblast Growth Factors | Gastroenterology and Hepatology | Bone Density | drug therapy | chemically induced | complications | Gastroenterologi | drug effects | Liver Cirrhosis | blood | Bile Acids and Salts | etiology | Biliary | analogs & derivatives | adverse effects | therapeutic use
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Obeticholic acid, a farnesoid X receptor agonist, improves portal hypertension by two distinct pathways in cirrhotic rats
by Verbeke, Len and Farre, Ricard and Trebicka, Jonel and Komuta, Mina and Roskams, Tania and Klein, Sabine and Elst, Ingrid Vander and Windmolders, Petra and Vanuytsel, Tim and Nevens, Frederik and Laleman, Wim
Hepatology, ISSN 0270-9139, 06/2014, Volume 59, Issue 6, pp. 2286 - 2298
The farnesoid X receptor (FXR) is a nuclear bile acid receptor involved in bile acid homeostasis, hepatic and intestinal inflammation, liver fibrosis, and... 
PRESSURE | CELLS | INHIBITION | ENDOTHELIAL DYSFUNCTION | LIVER | NITRIC-OXIDE | BETA-BLOCKERS | GASTROENTEROLOGY & HEPATOLOGY | BILE-ACIDS | NUCLEAR RECEPTOR | PATHOPHYSIOLOGY | Hypertension, Portal - physiopathology | Rats, Wistar | Liver Cirrhosis - complications | Down-Regulation | Rats | Male | Receptors, Cytoplasmic and Nuclear - agonists | Random Allocation | Chenodeoxycholic Acid - analogs & derivatives | Hypertension, Portal - drug therapy | Liver Cirrhosis - chemically induced | Animals | Hypertension, Portal - etiology | Chenodeoxycholic Acid - therapeutic use | Chenodeoxycholic Acid - pharmacology | Signal Transduction - physiology | Liver Cirrhosis - physiopathology | Nitric Oxide Synthase Type III - metabolism | Drug Evaluation, Preclinical | Disease Models, Animal | Hypertension | Acids | Rodents | Nitric oxide | Hepatology | Bile | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Early features of acute-on-chronic alcoholic liver failure: a prospective cohort study
by Katoonizadeh, Aezam and Laleman, Wim and Verslype, Chris and Wilmer, Alexander and Maleux, Geert and Roskams, Tania and Nevens, Frederik
Gut, ISSN 0017-5749, 11/2010, Volume 59, Issue 11, pp. 1561 - 1569
Backgroundā€˜Acute-on-chronic liver failureā€™ (ACLF) is characterised in a more advanced stage by liver failure associated with multiple other end-organ failure.... 
INFLAMMATORY RESPONSE SYNDROME | IMMUNE PARALYSIS | SPONTANEOUS BACTERIAL PERITONITIS | CONSENSUS CONFERENCE | DISEASE | HEPATORENAL-SYNDROME | CIRRHOTIC-PATIENTS | SEPSIS | GASTROENTEROLOGY & HEPATOLOGY | RECIRCULATING SYSTEM | INTERNATIONAL-ASCITES-CLUB | Diagnosis, Differential | Liver - pathology | Prognosis | Prospective Studies | Liver Cirrhosis, Alcoholic - pathology | Humans | Middle Aged | Liver Failure - pathology | Liver Failure, Acute - diagnosis | Bilirubin - analysis | Liver Failure, Acute - etiology | Male | Hospitalization | Biopsy | Epidemiologic Methods | Liver Failure, Acute - pathology | Adult | Female | Aged | Chronic Disease | Early Diagnosis | Liver Cirrhosis, Alcoholic - complications | Liver Failure - diagnosis | Opportunistic Infections - complications | Infection | Complications and side effects | Liver failure | Patient outcomes | Multiple organ failure | Diagnosis | Risk factors | Studies | Liver diseases | Transplants & implants | Mortality | Rodents | Medical prognosis | Infections | Multivariate analysis | Liver cirrhosis | Patients | Viral infections | Chronic illnesses | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Global genotype distribution of hepatitis C viral infection among people who inject drugs
by Robaeys, Geert and Bielen, Rob and Azar, Darush Ghezel and Razavi, Homie and Nevens, Frederik
Journal of Hepatology, ISSN 0168-8278, 2016, Volume 65, Issue 6, pp. 1094 - 1103
Background & Aims Hepatitis C viral infection (HCV) after injection drug use is very prevalent. The kind of genotype determines the response to treatment.... 
Gastroenterology and Hepatology | Genotype | Systematic review | People who inject drugs | Hepatitis C | PWID | VIRUS-INFECTION | RISK-FACTORS | FIBROSIS PROGRESSION | LIVER-DISEASE | NATURAL-HISTORY | HCV GENOTYPES | PLUS SOFOSBUVIR | MOLECULAR EPIDEMIOLOGY | NS5B REGION | GASTROENTEROLOGY & HEPATOLOGY | HIGH PREVALENCE | Europe | Humans | Africa | Substance Abuse, Intravenous | Drug Users | Drugs | Hepatitis C virus | Health aspects | Hepatitis | Genotype & phenotype | Epidemics | Reviews | Intravenous administration | Injection | Epidemiology | Drug use | Genotypes | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text Histological diversity in cholangiocellular carcinoma reflects the different cholangiocyte phenotypes
by Komuta, Mina and Govaere, Olivier and Vandecaveye, Vincent and Akiba, Jun and Van Steenbergen, Werner and Verslype, Chris and Laleman, Wim and Pirenne, Jacques and Aerts, Raymond and Yano, Hirohisa and Nevens, Frederik and Topal, Baki and Roskams, Tania
Hepatology, ISSN 0270-9139, 06/2012, Volume 55, Issue 6, pp. 1876 - 1888
Cholangiocellular carcinoma (CC) originates from topographically heterogeneous cholangiocytes. The cylindrical mucinā€producing cholangiocytes are located in... 
DIAGNOSIS | HEPATOCELLULAR-CARCINOMA | STEM-CELLS | INTRAHEPATIC CHOLANGIOCARCINOMA | PROGNOSIS | LIVER | LINE | HEPATIC PROGENITOR CELLS | S100P | GASTROENTEROLOGY & HEPATOLOGY | EXPRESSION | Immunohistochemistry | Neoplasm Invasiveness | Calcium-Binding Proteins - analysis | Humans | Middle Aged | Male | Gene Expression Profiling | Magnetic Resonance Imaging | Cholangiocarcinoma - pathology | Aged, 80 and over | Adult | Bile Ducts, Intrahepatic | Female | Neoplasm Proteins - analysis | Aged | Bile Duct Neoplasms - pathology | Gene expression | Rodents | Tumors | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights